Kohl's, J.C. Penney and Nordstrom release disappointing earnings news, putting a damper on their sector.Retailread more
Bezos's comments give a rare glimpse into his interest in the auto industry. Amazon recently invested in two self-driving start-ups.Technologyread more
While investing often seems like a contrarian game where going against the flow feels like the better bet, the reality is that investors who bought the most-favored stocks...Hedge Fundsread more
See which stocks are posting big moves after the bell on Tuesday, May 21.Market Insiderread more
CBS plans to renew discussions for Starz with Lions Gate in the coming weeks, according to people familiar with the matter. If a deal happens, the remainder of Lions Gate...Technologyread more
"We are now embarking on a new Long March, and we must start all over again!" Xi Jinping said.Marketsread more
The economist thinks the Fed ought to pay more attention to financial markets when setting interest rates.The Fedread more
Connecticut state Sen. Alex Bergstein's divorce case with her husband, Morgan Stanley managing director Seth Bergstein, has exposed her new romantic relationship with her...Politicsread more
Donaldson was chief of staff to former White House counsel Don McGahn, who on Tuesday defied the Judiciary panel's subpoena to testify about special counsel Robert Mueller's...Politicsread more
As shopping has shifted online and styles have evolved, Ascena has been grappling with sagging sales and a large debt-load. Looking to stem the losses, Ascena is turning to...Retailread more
The scientific community is now struggling to grapple with the ethics of human germline editing as another woman pregnant with a gene-edited baby is soon due to give birth.Health and Scienceread more
WASHINGTON, Oct. 5, 2015 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading technology company providing advanced cloud-based data analytics and data-driven intervention platforms to the healthcare industry, will host a distinguished roster of healthcare, pharmaceutical and life sciences industry experts this week during its 2015 Client Congress. Taking place at The Ritz Carlton in Washington, D.C., from October 4-6, Client Congress will feature numerous notable speakers, including Peter Orszag, Ph.D., the former director of the Office of Management and Budget under President Obama; Niall Brennan, chief data officer of the Centers for Medicare & Medicaid Services (CMS); Elliott Fisher, M.D., director of the Dartmouth Institute for Health Policy and Clinical Practice; Daniel Mendelson, president of Avalere Health (now part of Inovalon); James Carville and Mary Matalin, famed political strategists; and dozens of additional industry leaders. The conference will be moderated by Susan Dentzer, senior policy adviser for the Robert Wood Johnson Foundation and former chief editor of the Journal of Health Affairs.
"As the size and complexity of healthcare continues to expand, the sophistication of technologies and best practices needed to achieve meaningful and differentiated results is also increasing," said Robert Wychulis, president of Inovalon. "The active exchange of ideas from such esteemed industry experts at Client Congress will undoubtedly elevate the dialogue and drive advancements that bring significant improvements and a quantifiable impact to the healthcare industry as a whole."
In attendance are hundreds of stakeholders from more than 100 managed care and ACO providers, senior policymakers from CMS, influential industry organizations, such as America's Health Insurance Plan (AHIP), the National Committee for Quality Assurance (NCQA) and Utilization Review Accreditation Commission (URAC), and senior leaders from physician associations, technology companies, pharmaceutical and life sciences companies.
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. Inovalon's unique achievement of value is delivered through the effective progression of Turning Data into Insight, and Insight into Action®. Large proprietary datasets, advanced integration technologies, sophisticated predictive analytics, data-driven intervention platforms, and deep subject matter expertise deliver a seamless, end-to-end capability that brings the benefits of big data and large-scale analytics to the point of care. Driven by data, Inovalon uniquely identifies gaps in care, quality, data integrity, and financial performance – while bringing to bear the unique capabilities to resolve them. Providing technology that supports hundreds of healthcare organizations in 98.2% of U.S. counties and Puerto Rico, Inovalon's cloud-based analytical and data-driven intervention platforms are informed by data pertaining to more than 769,000 physicians, 261,000 clinical facilities, and more than 123 million Americans providing a powerful solution suite that drives high-value impact, improving quality and economics for health plans, ACOs, hospitals, physicians, consumers and pharma/life-sciences researchers. Data Diagnostics™ is the intellectual property of Inovalon. For more information, visit www.inovalon.com.
Source:Inovalon Holdings, Inc.